STAT3 and hepatocellular carcinoma: Besides, SLC2A1-AS1 triggered the suppression of Glut1 expression, further resulting in the inhibition of glycolysis of hepatocellular carcinoma (HCC) by competitively binding to transketolase and signal transducer and activator of transcription 3 (STAT3) [34].